Be Cautious With HBV Drug Withdrawal
More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.
Source: medscape.com
Stay updated with breaking news from Grishma Hirode. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.